NEXGEL Files 8-K for Reg FD Disclosure on Common Stock & Warrants

Ticker: NXGLW · Form: 8-K · Filed: Jan 31, 2024 · CIK: 1468929

Nexgel, Inc. 8-K Filing Summary
FieldDetail
CompanyNexgel, Inc. (NXGLW)
Form Type8-K
Filed DateJan 31, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: regulatory-filing, transparency, compliance

TL;DR

**NEXGEL just dropped an 8-K for Reg FD, keeping everyone in the loop on their stock and warrants.**

AI Summary

NEXGEL, INC. filed an 8-K on January 31, 2024, to disclose that it is making certain information available to the public under Regulation FD. This filing indicates that the company is providing transparency regarding its common stock and warrants to purchase common stock. For investors, this means NEXGEL is fulfilling its regulatory obligations by ensuring all market participants have access to the same material information, which can help maintain fair trading practices and investor confidence.

Why It Matters

This filing ensures that all investors have equal access to important company information, preventing unfair advantages and promoting transparency in the market.

Risk Assessment

Risk Level: low — This 8-K is a routine regulatory filing for transparency and does not indicate any immediate financial or operational risks.

Analyst Insight

A smart investor would note this routine compliance filing, understanding it provides transparency but doesn't signal new operational or financial developments. It's a good reminder to stay informed on all regulatory disclosures.

Key Players & Entities

  • NEXGEL, INC. (company) — the registrant filing the 8-K
  • January 31, 2024 (date) — date of earliest event reported and filing date
  • Regulation FD (other) — the disclosure rule being satisfied
  • Common Stock (other) — one of the securities being disclosed
  • Warrants To Purchase Common Stock (other) — another security being disclosed

FAQ

What is the primary purpose of NEXGEL, INC.'s 8-K filing on January 31, 2024?

The primary purpose of NEXGEL, INC.'s 8-K filing on January 31, 2024, is to satisfy the requirements of Regulation FD Disclosure, making certain information publicly available.

What specific types of securities are mentioned in the context of this disclosure?

The filing specifically mentions 'Common Stock' and 'Warrants To Purchase Common Stock' as the securities related to the disclosure.

What is NEXGEL, INC.'s business address as stated in the filing?

NEXGEL, INC.'s business address is 2150 Cabot Boulevard West, Suite B, Langhorne, Pennsylvania, 19067.

What is the company's Central Index Key (CIK) according to the filing?

The company's Central Index Key (CIK) is 0001468929.

Under which SEC Act is this Form 8-K filed?

This Form 8-K is filed under the 1934 Act, as indicated by 'SEC ACT: 1934 Act'.

Filing Stats: 500 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-01-31 09:05:33

Key Financial Figures

  • $0.001 — ch registered Common Stock, par value $0.001 NXGL The Nasdaq Capital Market LLC

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 31, 2024 NEXGEL, INC . By: /s/ Adam Levy Adam Levy Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.